社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
点赞
1
回复
评论
收藏
编组 21备份 2
分享
矩形
点滴投资思考
12-18
$映恩生物-B(09606)$
DB-1310成为全球首款在此适应症上获FTD的HER3-ADC药物,这个适应症前景怎么样呢?
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
形状备份
1
举报
登录后可参与评论
评论
推荐
最新
暂无评论
热议股票
{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":512036365508856,"tweetId":"512036365508856","gmtCreate":1766035836820,"gmtModify":1766035838657,"author":{"id":4215229380786360,"idStr":"4215229380786360","authorId":4215229380786360,"authorIdStr":"4215229380786360","name":"点滴投资思考","avatar":"https://static.tigerbbs.com/b4ae5bf42d773a8ce825db7288bca792","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/09606\">$映恩生物-B(09606)$</a> DB-1310成为全球首款在此适应症上获FTD的HER3-ADC药物,这个适应症前景怎么样呢?</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/09606\">$映恩生物-B(09606)$</a> DB-1310成为全球首款在此适应症上获FTD的HER3-ADC药物,这个适应症前景怎么样呢?</body></html>","text":"$映恩生物-B(09606)$ DB-1310成为全球首款在此适应症上获FTD的HER3-ADC药物,这个适应症前景怎么样呢?","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/512036365508856","repostId":0,"isVote":1,"tweetType":1,"viewCount":174,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09606"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":93,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}